Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Japan
  4. Japan Exchange
  5. Japan Tissue Engineering Co., Ltd.
  6. News
  7. Summary
    7774   JP3389610001

JAPAN TISSUE ENGINEERING CO., LTD.

(7774)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Japan Tissue Engineering Co., Ltd. Do Not Provides Earnings Guidance for the Fiscal Year Ending March 31, 2021

07/30/2020 | 02:30am EST

Japan Tissue Engineering Co., Ltd. does not provided earnings guidance for the fiscal year ending March 31, 2021. The company announced that the 2019 novel coronavirus infection has spread worldwide and has a great impact on the business environment in Japan and overseas. Since there are many uncertainties that will affect the company's business due to the spread of infection, it is difficult to reasonably calculate the business forecast for the fiscal year ending March 2021 at this point. The company will make an announcement as soon as the situation has settled and it is possible to calculate the earnings forecast.


ę S&P Capital IQ 2020
All news about JAPAN TISSUE ENGINEERING CO., LTD.
11/26Japan Tissue Starts Clinical Trial of Treatment for Dermal Burns
MT
11/24Japan Tissue Engineering Co., Ltd. Announces Start of Clinical Trial for Allogeneic Cul..
CI
10/29Japan Tissue Engineering Co., Ltd. Reports Earnings Results for the Half Year Ended Sep..
CI
09/20JAPAN TISSUE ENGINEERING CO., LTD.(J : 7774) dropped from S&P Global BMI Index
CI
09/14Japan Tissue Engineering Co., Ltd. Announces Approval of Autologous Cultured Oral Mucos..
CI
07/30Japan Tissue Engineering Co., Ltd. Reports Earnings Results for the First Quarter Ended..
CI
07/30Japan Tissue Engineering Co., Ltd. Provides Earnings Guidance for the Year Ending March..
CI
06/17Japan Tissue Engineering Co., Ltd. Announces Approval Obtained for Autologous Cultured ..
CI
05/24Japan Tissue Engineering Co., Ltd. Announces Marketing Approval of Autologous Cultured ..
CI
04/28Japan Tissue Engineering Co., Ltd. Provides Earnings Guidance for Fiscal Year Ending Ma..
CI
More news
Financials
Sales 2022 3 602 M 31,7 M 31,7 M
Net income 2022 234 M 2,06 M 2,06 M
Net Debt 2022 - - -
P/E ratio 2022 104x
Yield 2022 1,34%
Capitalization 24 285 M 213 M 214 M
Capi. / Sales 2022 6,74x
Capi. / Sales 2023 5,22x
Nbr of Employees 200
Free-Float 27,6%
Chart JAPAN TISSUE ENGINEERING CO., LTD.
Duration : Period :
Japan Tissue Engineering Co., Ltd. Technical Analysis Chart | 7774 | JP3389610001 | MarketScreener
Technical analysis trends JAPAN TISSUE ENGINEERING CO., LTD.
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Mean consensus -
Number of Analysts 0
Last Close Price 598,00 
Average target price
Spread / Average Target -
EPS Revisions
Managers and Directors
Ken-ichiro Hata Executive President & Representative Director
Yukio Mori Executive Officer & Manager-Production Technology
Masukazu Iie Executive Officer, Manager-Research & Development
Masahito Obayashi Head-Personnel, Accounting & Compliance
Toshihiro Osuka Director & Senior Managing Executive Officer
Sector and Competitors